Please wait while we open this resource.
K
Clinical reviews
HYPERCALCEMIA: A REVIEW
Marcella Donovan Walker, MD; Elizabeth Shane, MD
PDF202213 pages397 KB
Hypercalcemia affects approximately 1% of the global population and can range from mild, often asymptomatic cases to severe, life-threatening conditions. The review highlights that primary hyperparathyroidism and malignancy are the most common causes of hypercalcemia. It also details the clinical manifestations, diagnostic approaches, and treatment strategies, including hydration and pharmacological interventions. The importance of distinguishing between PTH-dependent and PTH-independent causes is underscored, along with the need for tailored treatment based on the underlying etiology.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
ADA Consensus Report: MASLD in People With Diabetes
Same clinical topic · Endocrinology
2025 ADA Diabetes Care Standards Updates
Same clinical topic · Endocrinology
METFORMIN―MECHANISMS OF ITS GLYCEMIA-REDUCING EFFECT
Same clinical topic · Endocrinology
SYNDROME OF INAPPROPRIATE ANTIDIURESIS: FROM PATHOPHYSIOLOGY TO MANAGEMENT
Same clinical topic · Endocrinology
GLYCEMIC EMERGENCIES
Same clinical topic · Endocrinology
DIAGNOSIS AND MANAGEMENT OF CENTRAL DIABETES INSIPIDUS IN ADULTS
Same clinical topic · Endocrinology
ANTI-OBESITY DRUGS: COMPREHENSIVE REVIEW AND EMERGING THERAPIES
Same clinical topic · Endocrinology
DRUG DELIVERY SYSTEMS FOR THYROID DISEASE TREATMENT: A MINI REVIEW ON CURRENT THERAPIES AND ALTERNATIVE APPROACHES
Same clinical topic · Endocrinology
OTHER BENEFITS OF CONTROLLING CARBOHYDRATES
Same clinical topic · Endocrinology